ISN Pioneer Awards honor the 'unsung heroes' of nephrology. They reward doctors on a regional level who have carried out extraordinary efforts to advance nephrology in a specific country or region. This is the first time that the North America and the Caribbean region has been included in the Pioneer Awards and nominations are allowed ONLY from...
The ISN is currently calling for applications from health care centers to become recognized as ISN Interventional Nephrology Training Centers. Such training centers work with the ISN to provide in-depth training in interventional nephrology to improve patient care in different regions of the world. Read the detailed guidelines on how to apply. Institutions from all countries (low, middle,...
The ISN supports clinical research projects that help detect and manage non-communicable chronic diseases such as CKD, AKI, hypertension, diabetes, and cardiovascular disease in emerging countries through the ISN Clinical Research Program (CRP). Three CRP investigators recently completed their research projects: Title of Grant: Acute Renal Failure in Children. Multicenter Prospective Cohort Study in Medium-Complexity Intensive Care...
There are only a few days left for ISN Members to nominate a deserving individual for one of the following 2021 awards: Alfred Newton Richards Award Roscoe R. Robinson Award Lillian Jean Kaplan International Prize for Advancement in the Understanding of Polycystic Kidney Disease Pioneer Awards Discover more on ISN Awards and the nomination requirements HERE. Award winners will be recognized at The ISN World Congress of Nephrology...
Applications are open until October 31, 2020. Click here to apply The year-long ISN-ANIO Clinical Nephropathology Certificaten Basic Program includes over 40 recorded online lectures and 12 live monthly webinars cover the main principles and practices of Nephropathology. Discover more here. "This is a wonderful course, did this last year. Highly recommended for fellows and early career nephrologists." Aakash Shingada, Director...
This longitudinal studyassessedfatigue and treatment status in patients with Atypical hemolytic uremic syndrome (aHUS) from the Global aHUS Registry. The results confirm the detrimental effects of aHUS on patients’ daily lives, especially in terms of fatigue,butdemonstratessignificant improvement in symptoms following treatment with eculizumab.
In response to factors such as climate change, unsustainable kidney-treatment methods, and CKD epidemics due to toxins and extreme working conditions, the authors urge nephrologists to pay particular attention to the effects of global warming and its potential to cause acute and chronic kidney injury, severe dehydration, and electrolyte disturbances. The authors propose a “planetary health” approach...
The ISN-ACT Global Trials Focus team has collected and published a new list of randomized research from nephrologists around the world for August 2020. Each trial is reviewed in context and the risk of bias in seven key areas is assessed. Highlight: Allopurinol does not slow the progression of chronic kidney disease in patients with type 1...
The full DAPA-CKD trial results will be presented and reviewed at the ESC Congress 2020, Sunday, August 30, 17:00 – 17:30 CET. Topic Renal failure and Cardiovascular Disease Chairpersons Rory Collins (Oxford, UK); Frank Ruschitzka (Zurich, Switzerland) Presentations: DAPA-CKD – Dapagliflozin in Patients with CKD: Hiddo Heerspink (Groningen, Netherlands) DAPA- CKD – Live Prime Discussion: Diederick E Grobbee (Utrecht, Netherlands) Q&A Session The...
The ISN will contribute to a panel discussion, « A Global Perspective on Kidney Failure” at the Innovations in Dialysis Expediting Advances Symposium (IDEAS) on August 31, 2020. Representing the ISN on the panel are: Vivekanand Jha, Executive Director at The George Institute for Global Health, India, Chair of Global Kidney Health, Imperial College of London, President, International Society of Nephrology (ISN) and Aminu Bello, Professor of Medicine, University of...
The ISN invites nephrologists to register patients affected by COVID-19 on the new global COVID registry. The ISN collaborated with the University of Cambridge to develop CORONATION, the Coronavirus multinational observational registry, a data entry portal accessible to nephrologists worldwide to collect anonymous data on individual people with kidney disease and the COVID-19 infection. For more information, please visit...
Kidney International will shortly publish the International Consensus Definitions of Clinical Trial Outcomes for Kidney Failure: 2020, developed from the 1st International Consensus Meeting on Defining Kidney Failure in Clinical Trials hosted by the ISN in Vancouver, BC, Canada, in early 2020. This is the first attempt by the international nephrology community to identify reproducible,...
Help shape the future of ISN: Nominate a potential candidate for the positions of 2021-23: President-Elect, and Regional Board Deputy Chairs/Councillors; 1 vacancy in each of the 10 ISN regions As an ISN member, you can help advance kidney care worldwide by nominating candidates for ISN leadership positions. The ISN is committed to the principles of diversity and inclusion....
The ISN invites members to register patients affected by COVID on the new global COVID registry. The ISN collaborated with the University of Cambridge to develop CORONATION, the Coronavirus multinational observational registry, a data entry portal accessible to nephrologists worldwide to collect anonymous data on individual people with kidney disease and the COVID-19 infection. The initiative was led...
Stefaan Claus, RN Nephrology Division, Ghent University Hospital, Ghent, Belgium Member of the ISN Kidney Health Professionals Working Group In October 2019, the ISN organized a Continuing Nurse Education (CNE) program at the Kenyatta University Hospital Nairobi, Kenya. One year earlier, in 2018, Professor Marie Richards, along with the local nurses in the renal unit and the heads...
The ISN and Asian Pacific Society of Nephrology (APSN) have sustained a successful collaboration over the last decade, working together to advance kidney care in the Asia-Pacific region. The ISN is pleased to share with members that the APSN’s 18th Asian Pacific Congress of Nephrology (APCN) will take place from 2-4 October 2020 at the Hong...
Young ISN members from Bangladesh, Ghana, and Brazil reflect on their experiences on the frontline of the COVID-19 pandemic. Read reflections from other young ISN members here. Find resources relating to the COVID-19 infection here. Reflections from Dhaka Tania Mahbub, Consultant Nephrologist, ISN Fellow, United Hospital Limited, Dhaka, Bangladesh Since it is a novel disease, the modus operandi of COVID-19 management has...
Every month the ISN-ACT Team lists interesting new randomized controlled trials from around the world. Highlight: Early ACE-inhibition is safe in pediatric Alport’s Syndrome and may be effective See the latest trials here
The ISN, in collaboration with the Mario Negri Institute for Pharmacological Research, will hold the ISN 2021 Frontiers Meeting on ‘Complement-related kidney diseases: classification, genetics, and treatment’ from July 1-3, in Bergamo, Italy. This specialist meeting will focus on the two prototypical complement-mediated kidney diseases: atypical hemolytic uremic syndrome (aHUS), and C3 Glomerulopathies/Membranoproliferative Glomerulonephritis (C3G/MPGN),...
